APO Research

APO RESEARCH · REPORT

Gingivitis Medicine

Selected research

Market Analysis & Forecast

Global Gingivitis Medicine Market Analysis and Forecast 2026-2032

Market perspective

The global Gingivitis Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gingivitis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gingivitis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gingivitis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gingivitis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gingivitis Medicine include Lion Corporation, OraPharma Inc, Sunstar Group, GlaxoSmithKline, Hainan Jianke Pharmaceutical, Jiangsu Chenpai Pharmaceutical and South China Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gingivitis Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gingivitis Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Gingivitis Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gingivitis Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gingivitis Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gingivitis Medicine sales, projected growth trends, production technology, application and end-user industry.

Gingivitis Medicine Segment by Company

Lion Corporation

OraPharma Inc

Sunstar Group

GlaxoSmithKline

Hainan Jianke Pharmaceutical

Jiangsu Chenpai Pharmaceutical

South China Pharmaceutical

Gingivitis Medicine Segment by Type

Iodine Glycerol

Chlorhexidine

Hydrochloride

Gingivitis Medicine Segment by Application

Ointment

Mouthwash

Toothpaste

Gingivitis Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gingivitis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gingivitis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gingivitis Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gingivitis Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gingivitis Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gingivitis Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gingivitis Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Iodine Glycerol Major Manufacturers Table 3. Chlorhexidine Major Manufacturers Table 4. Hydrochloride Major Manufacturers Table 5. Global Gingivitis Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Ointment Major Manufacturers Table 7. Mouthwash Major Manufacturers Table 8. Toothpaste Major Manufacturers Table 9. Gingivitis Medicine Industry Trends Table 10. Gingivitis Medicine Industry Drivers Table 11. Gingivitis Medicine Industry Opportunities and Challenges Table 12. Gingivitis Medicine Industry Restraints Table 13. Global Gingivitis Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Gingivitis Medicine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Gingivitis Medicine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Gingivitis Medicine Revenue Market Share by Region (2021-2026) Table 17. Global Gingivitis Medicine Revenue Market Share by Region (2027-2032) Table 18. Global Gingivitis Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Gingivitis Medicine Sales by Region (2021-2026) & (K Units) Table 20. Global Gingivitis Medicine Sales by Region (2027-2032) & (K Units) Table 21. Global Gingivitis Medicine Sales Market Share by Region (2021-2026) Table 22. Global Gingivitis Medicine Sales Market Share by Region (2027-2032) Table 23. Global Gingivitis Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Gingivitis Medicine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Gingivitis Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gingivitis Medicine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Gingivitis Medicine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Gingivitis Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Gingivitis Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Gingivitis Medicine Manufacturers, Product Type & Application Table 31. Global Gingivitis Medicine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Gingivitis Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Gingivitis Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Gingivitis Medicine Revenue Market Share by Type (2021-2026) Table 38. Global Gingivitis Medicine Revenue Market Share by Type (2027-2032) Table 39. Global Gingivitis Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 41. Global Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 42. Global Gingivitis Medicine Sales Market Share by Type (2021-2026) Table 43. Global Gingivitis Medicine Sales Market Share by Type (2027-2032) Table 44. Global Gingivitis Medicine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Gingivitis Medicine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Gingivitis Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Gingivitis Medicine Revenue Market Share by Application (2021-2026) Table 50. Global Gingivitis Medicine Revenue Market Share by Application (2027-2032) Table 51. Global Gingivitis Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 53. Global Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 54. Global Gingivitis Medicine Sales Market Share by Application (2021-2026) Table 55. Global Gingivitis Medicine Sales Market Share by Application (2027-2032) Table 56. Global Gingivitis Medicine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Gingivitis Medicine Price by Application (2027-2032) & (US$/Unit) Table 58. Lion Corporation Company Information Table 59. Lion Corporation Business Overview Table 60. Lion Corporation Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lion Corporation Gingivitis Medicine Product Portfolio Table 62. Lion Corporation Recent Development Table 63. OraPharma Inc Company Information Table 64. OraPharma Inc Business Overview Table 65. OraPharma Inc Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. OraPharma Inc Gingivitis Medicine Product Portfolio Table 67. OraPharma Inc Recent Development Table 68. Sunstar Group Company Information Table 69. Sunstar Group Business Overview Table 70. Sunstar Group Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sunstar Group Gingivitis Medicine Product Portfolio Table 72. Sunstar Group Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Gingivitis Medicine Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Hainan Jianke Pharmaceutical Company Information Table 79. Hainan Jianke Pharmaceutical Business Overview Table 80. Hainan Jianke Pharmaceutical Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hainan Jianke Pharmaceutical Gingivitis Medicine Product Portfolio Table 82. Hainan Jianke Pharmaceutical Recent Development Table 83. Jiangsu Chenpai Pharmaceutical Company Information Table 84. Jiangsu Chenpai Pharmaceutical Business Overview Table 85. Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Product Portfolio Table 87. Jiangsu Chenpai Pharmaceutical Recent Development Table 88. South China Pharmaceutical Company Information Table 89. South China Pharmaceutical Business Overview Table 90. South China Pharmaceutical Gingivitis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. South China Pharmaceutical Gingivitis Medicine Product Portfolio Table 92. South China Pharmaceutical Recent Development Table 93. North America Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 96. North America Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 97. North America Gingivitis Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Gingivitis Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 102. North America Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 103. North America Gingivitis Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Gingivitis Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Gingivitis Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Gingivitis Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Gingivitis Medicine Sales by Country (2021-2026) & (K Units) Table 110. North America Gingivitis Medicine Sales by Country (2027-2032) & (K Units) Table 111. North America Gingivitis Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Gingivitis Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 114. Canada Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 115. Europe Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 118. Europe Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 119. Europe Gingivitis Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Gingivitis Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 124. Europe Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 125. Europe Gingivitis Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Gingivitis Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Gingivitis Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Gingivitis Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Gingivitis Medicine Sales by Country (2021-2026) & (K Units) Table 132. Europe Gingivitis Medicine Sales by Country (2027-2032) & (K Units) Table 133. Europe Gingivitis Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Gingivitis Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 136. France Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 137. U.K. Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 138. Italy Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 140. China Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 141. China Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 142. China Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 143. China Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 144. China Gingivitis Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Gingivitis Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 147. China Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 148. China Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 149. China Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 150. China Gingivitis Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Gingivitis Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 155. Asia Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 156. Asia Gingivitis Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Gingivitis Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 161. Asia Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 162. Asia Gingivitis Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Gingivitis Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Gingivitis Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Gingivitis Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Asia Gingivitis Medicine Sales by Country (2021-2026) & (K Units) Table 169. Asia Gingivitis Medicine Sales by Country (2027-2032) & (K Units) Table 170. Asia Gingivitis Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Gingivitis Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 173. South Korea Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 174. India Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 175. Australia Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 176. China Taiwan Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Gingivitis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Gingivitis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Gingivitis Medicine Sales by Type (2021-2026) & (K Units) Table 181. SAMEA Gingivitis Medicine Sales by Type (2027-2032) & (K Units) Table 182. SAMEA Gingivitis Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Gingivitis Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Gingivitis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Gingivitis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Gingivitis Medicine Sales by Application (2021-2026) & (K Units) Table 187. SAMEA Gingivitis Medicine Sales by Application (2027-2032) & (K Units) Table 188. SAMEA Gingivitis Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Gingivitis Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Gingivitis Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Gingivitis Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. SAMEA Gingivitis Medicine Sales by Country (2021-2026) & (K Units) Table 195. SAMEA Gingivitis Medicine Sales by Country (2027-2032) & (K Units) Table 196. SAMEA Gingivitis Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Gingivitis Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 199. Argentina Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 200. Chile Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 201. Colombia Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 202. Peru Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 204. Israel Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 205. UAE Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 206. Turkey Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 207. Iran Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 208. Egypt Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Gingivitis Medicine Distributors List Table 212. Gingivitis Medicine Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Gingivitis Medicine Image Figure 2. Global Gingivitis Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gingivitis Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Iodine Glycerol Image Figure 5. Chlorhexidine Image Figure 6. Hydrochloride Image Figure 7. Global Gingivitis Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gingivitis Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Ointment Image Figure 10. Mouthwash Image Figure 11. Toothpaste Image Figure 12. Global Gingivitis Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gingivitis Medicine Revenue (2021-2032) & (US$ Million) Figure 14. Global Gingivitis Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Gingivitis Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Gingivitis Medicine Revenue Market Share by Region (2021-2032) Figure 17. Global Gingivitis Medicine Sales (2021-2032) & (K Units) Figure 18. Global Gingivitis Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Gingivitis Medicine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Gingivitis Medicine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Gingivitis Medicine Sales YoY (2021-2032) & (K Units) Figure 22. China Gingivitis Medicine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Gingivitis Medicine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Gingivitis Medicine Sales YoY (2021-2032) & (K Units) Figure 25. Global Gingivitis Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Gingivitis Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Gingivitis Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gingivitis Medicine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Gingivitis Medicine Revenue Market Share by Type (2021-2032) Figure 31. Global Gingivitis Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Gingivitis Medicine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Gingivitis Medicine Sales Market Share by Type (2021-2032) Figure 34. Global Gingivitis Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Gingivitis Medicine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Gingivitis Medicine Revenue Market Share by Application (2021-2032) Figure 37. Global Gingivitis Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Gingivitis Medicine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Gingivitis Medicine Sales Market Share by Application (2021-2032) Figure 40. North America Gingivitis Medicine Revenue Share by Type (2021-2032) Figure 41. North America Gingivitis Medicine Sales Share by Type (2021-2032) Figure 42. North America Gingivitis Medicine Revenue Share by Application (2021-2032) Figure 43. North America Gingivitis Medicine Sales Share by Application (2021-2032) Figure 44. North America Gingivitis Medicine Revenue Share by Country (2021-2032) Figure 45. North America Gingivitis Medicine Sales Share by Country (2021-2032) Figure 46. Europe Gingivitis Medicine Revenue Share by Type (2021-2032) Figure 47. Europe Gingivitis Medicine Sales Share by Type (2021-2032) Figure 48. Europe Gingivitis Medicine Revenue Share by Application (2021-2032) Figure 49. Europe Gingivitis Medicine Sales Share by Application (2021-2032) Figure 50. Europe Gingivitis Medicine Revenue Share by Country (2021-2032) Figure 51. Europe Gingivitis Medicine Sales Share by Country (2021-2032) Figure 52. China Gingivitis Medicine Revenue Share by Type (2021-2032) Figure 53. China Gingivitis Medicine Sales Share by Type (2021-2032) Figure 54. China Gingivitis Medicine Revenue Share by Application (2021-2032) Figure 55. China Gingivitis Medicine Sales Share by Application (2021-2032) Figure 56. Asia Gingivitis Medicine Revenue Share by Type (2021-2032) Figure 57. Asia Gingivitis Medicine Sales Share by Type (2021-2032) Figure 58. Asia Gingivitis Medicine Revenue Share by Application (2021-2032) Figure 59. Asia Gingivitis Medicine Sales Share by Application (2021-2032) Figure 60. Asia Gingivitis Medicine Revenue Share by Country (2021-2032) Figure 61. Asia Gingivitis Medicine Sales Share by Country (2021-2032) Figure 62. SAMEA Gingivitis Medicine Revenue Share by Type (2021-2032) Figure 63. SAMEA Gingivitis Medicine Sales Share by Type (2021-2032) Figure 64. SAMEA Gingivitis Medicine Revenue Share by Application (2021-2032) Figure 65. SAMEA Gingivitis Medicine Sales Share by Application (2021-2032) Figure 66. SAMEA Gingivitis Medicine Revenue Share by Country (2021-2032) Figure 67. SAMEA Gingivitis Medicine Sales Share by Country (2021-2032) Figure 68. Gingivitis Medicine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gingivitis Medicine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Iodine Glycerol
  • Chlorhexidine
  • Hydrochloride
Applications
  • Ointment
  • Mouthwash
  • Toothpaste
Companies covered
  • Lion Corporation
  • OraPharma Inc
  • Sunstar Group
  • GlaxoSmithKline
  • Hainan Jianke Pharmaceutical
  • Jiangsu Chenpai Pharmaceutical
  • South China Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gingivitis Medicine Market by Type
  3. 1.2.1 Global Gingivitis Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Iodine Glycerol
  5. 1.2.3 Chlorhexidine
  6. 1.2.4 Hydrochloride
  7. 1.3 Gingivitis Medicine Market by Application
  8. 1.3.1 Global Gingivitis Medicine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Ointment
  10. 1.3.3 Mouthwash
  11. 1.3.4 Toothpaste
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gingivitis Medicine Market Dynamics
  1. 2.1 Gingivitis Medicine Industry Trends
  2. 2.2 Gingivitis Medicine Industry Drivers
  3. 2.3 Gingivitis Medicine Industry Opportunities and Challenges
  4. 2.4 Gingivitis Medicine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gingivitis Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gingivitis Medicine Revenue by Region
  3. 3.2.1 Global Gingivitis Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gingivitis Medicine Revenue by Region (2021-2026)
  5. 3.2.3 Global Gingivitis Medicine Revenue by Region (2027-2032)
  6. 3.2.4 Global Gingivitis Medicine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gingivitis Medicine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gingivitis Medicine Sales by Region
  9. 3.4.1 Global Gingivitis Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gingivitis Medicine Sales by Region (2021-2026)
  11. 3.4.3 Global Gingivitis Medicine Sales by Region (2027-2032)
  12. 3.4.4 Global Gingivitis Medicine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gingivitis Medicine Revenue by Manufacturers
  2. 4.1.1 Global Gingivitis Medicine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gingivitis Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gingivitis Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gingivitis Medicine Sales by Manufacturers
  6. 4.2.1 Global Gingivitis Medicine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gingivitis Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gingivitis Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gingivitis Medicine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gingivitis Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gingivitis Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gingivitis Medicine Manufacturers, Product Type & Application
  13. 4.7 Global Gingivitis Medicine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gingivitis Medicine Market CR5 and HHI
  16. 4.8.2 2025 Gingivitis Medicine Tier 1, Tier 2, and Tier 3
5 Gingivitis Medicine Market by Type
  1. 5.1 Global Gingivitis Medicine Revenue by Type
  2. 5.1.1 Global Gingivitis Medicine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gingivitis Medicine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gingivitis Medicine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gingivitis Medicine Sales by Type
  6. 5.2.1 Global Gingivitis Medicine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gingivitis Medicine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gingivitis Medicine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gingivitis Medicine Price by Type
6 Gingivitis Medicine Market by Application
  1. 6.1 Global Gingivitis Medicine Revenue by Application
  2. 6.1.1 Global Gingivitis Medicine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gingivitis Medicine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gingivitis Medicine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gingivitis Medicine Sales by Application
  6. 6.2.1 Global Gingivitis Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gingivitis Medicine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gingivitis Medicine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gingivitis Medicine Price by Application
7 Company Profiles
  1. 7.1 Lion Corporation
  2. 7.1.1 Lion Corporation Company Information
  3. 7.1.2 Lion Corporation Business Overview
  4. 7.1.3 Lion Corporation Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lion Corporation Gingivitis Medicine Product Portfolio
  6. 7.1.5 Lion Corporation Recent Developments
  7. 7.2 OraPharma Inc
  8. 7.2.1 OraPharma Inc Company Information
  9. 7.2.2 OraPharma Inc Business Overview
  10. 7.2.3 OraPharma Inc Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 OraPharma Inc Gingivitis Medicine Product Portfolio
  12. 7.2.5 OraPharma Inc Recent Developments
  13. 7.3 Sunstar Group
  14. 7.3.1 Sunstar Group Company Information
  15. 7.3.2 Sunstar Group Business Overview
  16. 7.3.3 Sunstar Group Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sunstar Group Gingivitis Medicine Product Portfolio
  18. 7.3.5 Sunstar Group Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Gingivitis Medicine Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Hainan Jianke Pharmaceutical
  26. 7.5.1 Hainan Jianke Pharmaceutical Company Information
  27. 7.5.2 Hainan Jianke Pharmaceutical Business Overview
  28. 7.5.3 Hainan Jianke Pharmaceutical Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hainan Jianke Pharmaceutical Gingivitis Medicine Product Portfolio
  30. 7.5.5 Hainan Jianke Pharmaceutical Recent Developments
  31. 7.6 Jiangsu Chenpai Pharmaceutical
  32. 7.6.1 Jiangsu Chenpai Pharmaceutical Company Information
  33. 7.6.2 Jiangsu Chenpai Pharmaceutical Business Overview
  34. 7.6.3 Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangsu Chenpai Pharmaceutical Gingivitis Medicine Product Portfolio
  36. 7.6.5 Jiangsu Chenpai Pharmaceutical Recent Developments
  37. 7.7 South China Pharmaceutical
  38. 7.7.1 South China Pharmaceutical Company Information
  39. 7.7.2 South China Pharmaceutical Business Overview
  40. 7.7.3 South China Pharmaceutical Gingivitis Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 South China Pharmaceutical Gingivitis Medicine Product Portfolio
  42. 7.7.5 South China Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Gingivitis Medicine Market Size by Type
  2. 8.1.1 North America Gingivitis Medicine Revenue by Type (2021-2032)
  3. 8.1.2 North America Gingivitis Medicine Sales by Type (2021-2032)
  4. 8.1.3 North America Gingivitis Medicine Price by Type (2021-2032)
  5. 8.2 North America Gingivitis Medicine Market Size by Application
  6. 8.2.1 North America Gingivitis Medicine Revenue by Application (2021-2032)
  7. 8.2.2 North America Gingivitis Medicine Sales by Application (2021-2032)
  8. 8.2.3 North America Gingivitis Medicine Price by Application (2021-2032)
  9. 8.3 North America Gingivitis Medicine Market Size by Country
  10. 8.3.1 North America Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gingivitis Medicine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gingivitis Medicine Market Size by Type
  2. 9.1.1 Europe Gingivitis Medicine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gingivitis Medicine Sales by Type (2021-2032)
  4. 9.1.3 Europe Gingivitis Medicine Price by Type (2021-2032)
  5. 9.2 Europe Gingivitis Medicine Market Size by Application
  6. 9.2.1 Europe Gingivitis Medicine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gingivitis Medicine Sales by Application (2021-2032)
  8. 9.2.3 Europe Gingivitis Medicine Price by Application (2021-2032)
  9. 9.3 Europe Gingivitis Medicine Market Size by Country
  10. 9.3.1 Europe Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gingivitis Medicine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gingivitis Medicine Market Size by Type
  2. 10.1.1 China Gingivitis Medicine Revenue by Type (2021-2032)
  3. 10.1.2 China Gingivitis Medicine Sales by Type (2021-2032)
  4. 10.1.3 China Gingivitis Medicine Price by Type (2021-2032)
  5. 10.2 China Gingivitis Medicine Market Size by Application
  6. 10.2.1 China Gingivitis Medicine Revenue by Application (2021-2032)
  7. 10.2.2 China Gingivitis Medicine Sales by Application (2021-2032)
  8. 10.2.3 China Gingivitis Medicine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gingivitis Medicine Market Size by Type
  2. 11.1.1 Asia Gingivitis Medicine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gingivitis Medicine Sales by Type (2021-2032)
  4. 11.1.3 Asia Gingivitis Medicine Price by Type (2021-2032)
  5. 11.2 Asia Gingivitis Medicine Market Size by Application
  6. 11.2.1 Asia Gingivitis Medicine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gingivitis Medicine Sales by Application (2021-2032)
  8. 11.2.3 Asia Gingivitis Medicine Price by Application (2021-2032)
  9. 11.3 Asia Gingivitis Medicine Market Size by Country
  10. 11.3.1 Asia Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gingivitis Medicine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gingivitis Medicine Market Size by Type
  2. 12.1.1 SAMEA Gingivitis Medicine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gingivitis Medicine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gingivitis Medicine Price by Type (2021-2032)
  5. 12.2 SAMEA Gingivitis Medicine Market Size by Application
  6. 12.2.1 SAMEA Gingivitis Medicine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gingivitis Medicine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gingivitis Medicine Price by Application (2021-2032)
  9. 12.3 SAMEA Gingivitis Medicine Market Size by Country
  10. 12.3.1 SAMEA Gingivitis Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gingivitis Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gingivitis Medicine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gingivitis Medicine Value Chain Analysis
  2. 13.1.1 Gingivitis Medicine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gingivitis Medicine Production Mode & Process
  6. 13.2 Gingivitis Medicine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gingivitis Medicine Distributors
  9. 13.2.3 Gingivitis Medicine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research